vimarsana.com

Page 6 - பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் ப்ரைம் தரநிலை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biofrontera reports results for the 2020 financial year

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Biofrontera reports results for the 2020 financial year Biofrontera AGApril 12, 2021 GMT Leverkusen, Germany, April 12, 2021 (GLOBE NEWSWIRE) Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its consolidated results for the fiscal year ended December 31, 2020. At the same time, the Company provided an overview of current operational and clinical developments. Key financial figures FY2020 Revenue decreased by 3% to EUR 30.3 million compared to EUR 31.3 million in 2019; Loss from operations amounted to EUR 7.6 million compared to a loss of EUR 23.4 million in 2019;

PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM

PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM DGAP-News: PAION AG / Key word(s): Market launch 07.04.2021 / 09:00 PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO TM (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM Aachen (Germany), 07 April 2021 - The Specialty Pharma Company PAION AG (PA8; ISIN DE000A0B65S3; Frankfurt Stock Exchange Prime Standard) today announces that Hana Pharm, remimazolam licensee for South Korea, informed PAION about the launch of Byfavo TM (remimazolam) for the use in general anesthesia in South Korea. Remimazolam was approved in South Korea for general anesthesia in January 2021 and will be marketed under the brand name Byfavo

SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22 5%

SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22.5%. DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): Development of Sales/Preliminary Results 07.04.2021 / 07:00 SHOP APOTHEKE EUROPE: Fast growth continues, Q1 revenues up 22.5%. Preliminary sales growth of 22.5% in Q1 to EUR 284 million. DACH segment +15%, International segment +71%. Total number of active customers up 0.5 million in Q1 to 6.8 million (year-over-year up 1.8 million). Venlo, 7 April 2021. SHOP APOTHEKE EUROPE N.V. continued to grow dynamically in the first three months of the 2021 financial year. According to preliminary unaudited calculations, total group sales rose by 22.5% to EUR 284 million after EUR 232 million in Q1 last year. Stefan Feltens, CEO of SHOP APOTHEKE EUROPE, comments: We are proud that we gained another record number of new customers across Europe. We achieved this despite the absence of a cold and flu season as a result of Covid-related social distancing measures this

Investegate |PAION AG Announcements | PAION AG: PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM

Investegate |PAION AG Announcements | PAION AG: PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO (REMIMAZOLAM) IN SOUTH KOREA BY HANA PHARM
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.